
Share on:
Shanghai Sanyou Medical received a $14.0MM investment from Chinese investment firm Yingke Private Equity. Sanyou plans to use the funds to invest in research and development, as well as accelerate its initial public offering process.
Founded in 2005, the orthopaedic device developer holds 21 patents and 48 utility models in China. Products include “Z” Minimally Invasive Spine Technology that purportedly reduces surgery time by 50% and surgical incision size by 30%. The company’s Tytus Labs offers R&D assistance from prototyping to mechanical and biomechanical analysis.
As a startup, the company raised Series A funds with investments from Qiming Venture Partners and TF Capital in 2014.
Sources: Shanghai Sanyou Medical
RELATED ARTICLES
4D Medicine to Showcase Breakthrough Biomaterials at OMTEC 2025
Jun 06 2025 , Julie A. Vetalice
Placon Announces New Costa Rica Warehouse and Distribution Facility
Jun 02 2025 , Julie A. Vetalice
On a Mission to Create Equity in Worldwide Orthopedic Care
May 28 2025 , BONEZONE Editors